Correlation Between Inhibrx and Pardes Biosciences
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Pardes Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Pardes Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Pardes Biosciences, you can compare the effects of market volatilities on Inhibrx and Pardes Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Pardes Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Pardes Biosciences.
Diversification Opportunities for Inhibrx and Pardes Biosciences
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inhibrx and Pardes is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Pardes Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pardes Biosciences and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Pardes Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pardes Biosciences has no effect on the direction of Inhibrx i.e., Inhibrx and Pardes Biosciences go up and down completely randomly.
Pair Corralation between Inhibrx and Pardes Biosciences
If you would invest 214.00 in Pardes Biosciences on October 24, 2024 and sell it today you would earn a total of 0.00 from holding Pardes Biosciences or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.69% |
Values | Daily Returns |
Inhibrx vs. Pardes Biosciences
Performance |
Timeline |
Inhibrx |
Pardes Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibrx and Pardes Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Pardes Biosciences
The main advantage of trading using opposite Inhibrx and Pardes Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Pardes Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will offset losses from the drop in Pardes Biosciences' long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Pardes Biosciences vs. Shattuck Labs | Pardes Biosciences vs. Champions Oncology | Pardes Biosciences vs. Century Therapeutics | Pardes Biosciences vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Managers Screen money managers from public funds and ETFs managed around the world |